Read our latest guidance, updates and FAQs on Brexit.
Last updated: 26 January 2021
Read our guidance on EORI numbers and clinical trial supplies.
On 22 December 2020 the JRO updated its position statement on our UCL clinical trials portfolio in relation to Brexit.
The update includes reference to the Northern Ireland Protocol – the current position is that Northern Ireland will remain in compliance with EU legislation and comply with EU requirements with respect to medicinal products and medical devices.
It also sets out information on freight services to support the uninterrupted delivery of medicines and medicinal products.
The Department of Health and Social Care (DHSC) has released guidance to sponsors of clinical trials, to ensure all patients taking part in clinical trials and clinical investigations continue to have access to medicines and medical products.
On 5 January 2021 the HRA released guidance setting out what sponsors need to do from 1 January.
Researchers with questions on Brexit can contact: firstname.lastname@example.org.
Image: CHATCHAI / Adobe Stock